Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities research analysts expect Aadi Bioscience Inc (NASDAQ:AADI – Get Rating) to report $390,000.00 in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Aadi Bioscience’s earnings. The lowest sales estimate is $250,000.00 and the highest is $540,000.00. The firm is expected to issue its next earnings results […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) announced its quarterly earnings data on Thursday. The company reported ($0.77) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.82) by $0.05, MarketWatch Earnings reports. Shares of NASDAQ:AADI traded down $0.54 during trading on Friday, reaching $18.95. The stock had a trading volume […]
Fyarro is now available for locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.
Fyarro is now available for locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.
Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different.